Veeva Systems Inc. ( NYSE:VEEV ) recently posted some strong earnings, and the market responded positively. We ...

Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that ...

As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on ...

Veeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

EVERSANA – pharmaphorum's parent company – said it has met the standard to join Veeva's partner programme and will now be ...

Shares of Veeva Systems Inc. (NYSE:VEEV – Get Free Report) have been assigned an average recommendation of “Moderate Buy” ...

Veeva Systems Inc. (NYSE:VEEV), a leading provider of cloud-based software solutions for the global life sciences industry with a market capitalization of $37.4 billion, continues to navigate a ...

Research analysts at Zacks Research upped their Q1 2026 earnings per share estimates for Veeva Systems in a report released on Wednesday, March 26th. Zacks Research analyst R. Department now ...

Veeva Systems's VEEV short percent of float has fallen 10.0% since its last report. The company recently reported that it has ...

PLEASANTON, Calif., April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that is integrated with ...

Veeva Systems shines with 14% revenue growth, CRM adoption momentum, and Data Cloud innovations. Read why VEEV stock is a strong buy for 2025.

Veeva Systems (NYSE: VEEV) today announced that Indero, formerly Innovaderm Research, successfully launched its 40th RTSM ...